Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

R&D costs rise ten-fold

December 4, 2012 Research and Development, Sales and Marketing OHE, R&D, research and development

Research by the Office of Health Economics (OHE) think tank shows that the cost of pharma R&D has risen ten-fold …
News

NHS ‘entering treacherous waters’

December 3, 2012 Sales and Marketing Ham, NHS, coalition, king's fund, reforms

A leading think tank has marked the coalition government’s health policy with what amounts to a C+ in its mid-term …
News

J&J’s Alex Gorsky to be chairman and chief executive

December 3, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Johnson & Johnson has has elected its chief executive Alex Gorsky to be its chairman of the Board of directors.  …
Appointment

Janssen eases HIV patent burden

December 3, 2012 Sales and Marketing AIDS, Janssen, Prezista, darunavir

In a move which should appeal to public health campaigners, Janssen has declared that it will not enforce patents for …
News

Help CCGs help you, pharma told

November 30, 2012 Medical Communications, Sales and Marketing CCGs, JSNA, NHS, pharma

Pharma companies have a big opportunity to take advantage of the changes in the structure of the NHS, according to …
News

New chief executive for Cipla

November 30, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Cipla, Subhanu Saxena

Indian pharma firm Cipla has announced the appointment of Novartis’ Subhanu Saxena as its chief executive. Saxena joins Cipla in …
Appointment

NICE: ‘lot of work’ to do on VBP

November 30, 2012 Medical Communications, Sales and Marketing Boysen, NHS, NICE, QALY, VBP

NICE is still working out what its role with the new NHS Commissioning Board will be, with other key issues …
News

Novartis R&D warning

November 29, 2012 Research and Development, Sales and Marketing NHS, Novartis. R&D, trials

Novartis has hit out at what it sees as the high cost of UK clinical trials, warning that business will …
News

Eylea approval for wet AMD

November 29, 2012 Sales and Marketing Bayer, Eylea, Lucentis, Novartis, avastin, wet AMD

Bayer HealthCare’s Eylea has been appoved in Europe for the treatment of neovascular age-related macular degeneration (wet AMD). The eye …
News

Genzyme appoints new GM for UK and Ireland

November 29, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brendan Martin, Genzyme

Genzyme has announced the appointment of Brendan Martin as general manager for UK and Ireland. Martin will be responsible for …
Appointment

Survey: pharma losing $564 billion each year

November 28, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cap Gemini, Health Prize, pharma

Pharma companies are losing $564 billion each year – more than half the industry’s $956 billion revenue worldwide last year …
News

Another indication for Humira

November 28, 2012 Sales and Marketing Abbott, Crohn's, EU, Humira

Abbott’s Humira has received its ninth indication in Europe with approval to treat youngsters suffering from the inflammatory bowel disease …
News

RSA welcomes new starter

November 28, 2012 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huberts, rsa

Life Sciences Executive Search and Interim Management specialists RSA, has announced that Michael Huberts has joined the UK business as …
Appointment

EMA’s five points on data release

November 27, 2012 Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Rasi, transparency

The European Medicines Agency has highlighted five areas that need to be ironed out before it begins publishing clinical trial …
News

‘Adopt NICE decisions’ committee told

November 27, 2012 Sales and Marketing ABPI, Dorrell, NHS, NICE, Whitehead

ABPI chief executive Stephen Whitehead has again urged the NHS to adopt and use the drugs which NICE approves, and …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026